Richmond Pharmacology is pleased to confirm our attendance at the FPM Annual Symposium 2025 in London, a leading event hosted by the Faculty of Pharmaceutical Medicine, dedicated to advancing professional excellence in pharmaceutical medicine and clinical research.

The symposium will bring together clinicians, researchers, and industry leaders to discuss the latest developments in drug development, clinical pharmacology, and regulatory science.

Representing Richmond Pharmacology:
• Dr Lisa Campbell, Director of Regulatory Strategy

 

Dr Campbell will take a deep dive into pharmaceutical medicine’s future role in advancing the health of women, highlighting how innovation in research, regulation, and clinical practice can address unmet needs, improve equity, and shape the next generation of therapeutic development.

If you are attending the FPM Annual Symposium and would like to learn how Richmond Pharmacology can support your clinical development programmes, we welcome you to connect with us during the event.

For meeting requests or collaboration enquiries:
📧info@richmondpharmacology.com

Learn more about the event: FPM Annual Symposium 2025 'Innovation in times of global uncertainty'

 

Latest news

How Richmond Pharmacology Supports Sponsors Navigating ICH E6 (R3)

February 5, 2026
The updated ICH E6 (R3) guideline places greater emphasis on proportionality, risk-based oversight...
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event